Literature DB >> 29322628

Case of cecal volvulus successfully treated with endoscopic colopexy.

Yuki Sakamoto1,2, Yukiharu Hiyoshi2, Kazuya Sakata1, Eiichiro Toyama1, Noboru Takata1, Ichiro Yoshinaka1, Kazunori Harada1, Hideo Baba2.   

Abstract

We herein report a case of cecal volvulus successfully treated with endoscopic colopexy. A 73-year-old man with a high fever and abdominal fullness was diagnosed with ileus caused by cecal volvulus. CT showed a dilated cecum and small intestine without bowel strangulation as well as acute pneumonia. Because the pneumonia increased the risk associated with general anesthesia, we attempted decompression of the bowel using endoscopy to avoid surgery. On day 1, a transanal ileus tube was inserted to the terminal ileum through the dilated cecum. On day 7, the bowel torsion spontaneously released. On day 8, we performed percutaneous endoscopic colopexy to fix the cecum on the abdominal wall and prevent re-twisting. The patient was discharged on day 15 without postoperative complications. Percutaneous endoscopic colopexy for cecal volvulus may be a treatment option when the risk associated with general anesthesia or surgery is high because of a comorbidity.
© 2018 Japan Society for Endoscopic Surgery, Asia Endosurgery Task Force and John Wiley & Sons Australia, Ltd.

Entities:  

Keywords:  Cecal volvulus; colonic volvulus; percutaneous endoscopic colopexy

Mesh:

Year:  2018        PMID: 29322628     DOI: 10.1111/ases.12460

Source DB:  PubMed          Journal:  Asian J Endosc Surg        ISSN: 1758-5902


  2 in total

1.  Cecal volvulus in rural Kenya: delayed presentation contributes to high mortality.

Authors:  Kimutai R Sylvester; Philip B Ooko; Michael M Mwachiro; Robert K Parker
Journal:  BMC Surg       Date:  2021-12-19       Impact factor: 2.102

2.  Cecal Volvulus Resolved Spontaneously.

Authors:  Yosuke Kunishi; Megumi Tsukamoto; Takafumi Yanagibashi; Yuki Sodani; Kazuhiro Niwa; Koichiro Yoshie; Yoshio Kato; Shin Maeda
Journal:  Intern Med       Date:  2020-10-14       Impact factor: 1.271

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.